The popular blood thinner Rivaroxaban, sold under the name XARELTO, has been the subject of controversy lately due to risks of fatal internal bleeding and fatal brain hemorrhage. Xarelto is typically prescribed to reduce the risk of stroke and systemic embolism in patients with non valvular atrial fibrillation. It is also indicated as a prophylaxis of deep vein thrombosis, or DVT, which may lead to pulmonary embolism following knee or hip replacement surgery. Xarelto is an alternative to warfarin, which has been on the market for more than 60 years.
As per a survey, as of now more than 2,800 cases have been filed in federal courts across the nation claiming that the drug caused dangerous and often times fatal uncontrollable bleeding. In one Xarelto case, the plaintiff has filed a lawsuit on behalf of her father, who she claims in her court documents died as a result of excessive bleeding from an injury he experienced that caused bleeding in his brain. Doctors could not get his blood to clot due to his use of Xarelto.
- A lawsuit filed in February of 2014 in the Pennsylvania Court of Common Pleas, Philadelphia County on behalf of a Kentucky patient who claims to have developed uncontrolled subdural (brain) bleeding after taking Xarelto.
- In June, 2014 a lawsuit was filed against Bayer and Johnson & Johnson in the U.S District court for the southern District of Florida. The suit was filed by the wife of a patient who experienced uncontrolled bleeding died. The patient was on Xarelto medication.
- A lawsuit filed on July 25, 2014 in the U.S. District Court for the District of Vermont by the family of a man who died following uncontrolled brain bleeding. The bleeding episode occurred only 10 days after the patient began taking Xarelto.
- A Georgia man has filed a lawsuit against Bayer Healthcare, Johnson & Johnson, and its Janssen subsidiary, alleging that his consumption of Xarelto caused catastrophic intracranial bleeding. According to court documents, doctors instructed patient to begin taking the anticoagulant in 2013, as treatment for a heart condition. Several months later, he rushed to the hospital with serious brain bleeding, which caused serious and permanent injuries. His lawsuit demands unspecified damages.
According to the FDA, special care should also be taken by patients taking daily aspirin. While aspirin reportedly may help prevent a heart attack, when combined with another blood thinner like Xarelto, it can prove fatal in the event of a serious bleed. There have been so many lawsuits filed against the manufacturers for the same reason. Xarelto has been linked to serious side effects including the following:
Xarelto Side Effects
- Xarelto bleeding (Risk of uncontrollable internal bleeding, even brain hemorrhage)
- Heart Attack
- Spinal epidural hematoma (blood accumulating along the spine)
- A heightened risk of stroke
- Life-threatening allergies
- Liver conditions
- Abnormal liver function
- Nose bleeding
- Pulmonary embolism
The ever-growing number of Xarelto side effect lawsuits indicates that the drug was rushed to the market without adequate testing and brazenly promoted without warning of its fatal risks. Xarelto can increase bleeding, and can cause serious bleeding. There is allegedly no antidote to stop uncontrolled bleeding, which can lead Xarelto to cause someone to bleed to death. Lawsuits accuse the drug manufacturers of promoting Xarelto blood thinner as an easy to use and monitor anticoagulant.